“…IFN-γ has been proposed as a biomarker for dry eye disease and Sjögren syndrome (SS) because elevated IFN-γ, either protein and/or RNA, has been detected in tears, saliva, conjunctiva, submandibular glands and blood [tears (Boehm et al, 2011; Corrales et al, 2007; de Paiva et al, 2007a; Enriquez-de-Salamanca et al, 2010; Lam et al, 2008; Massingale et al, 2009; Mrugacz et al, 2006; Riemens et al, 2012), conjunctiva (Chen et al, 2011; Chen et al, 2006; Corrales et al, 2007; de Paiva et al, 2007a; Zhang et al, 2011b) , saliva (Kang et al, 2011; Pertovaara et al, 2006), lacrimal (de Paiva et al, 2010a; Hayashi et al, 2012; Jie et al, 2010; Ogawa et al, 2002; Pelegrino et al, 2012; Rahimy et al, 2010b; Viau et al, 2011) submandibular glands (Brookes et al, 1995; Hayashi et al, 2012; Koarada et al, 2006; Kohashi et al, 2008; Mrugacz et al, 2006), and blood (Hagiwara et al, 1998; Szodoray et al, 2008)] Evidence from mouse models and human SS patients indicate that IFN-γ is a relevant therapeutic target (de Paiva et al, 2007; de Paiva et al, 2011; Ogawa et al, 2002). …”